Document Detail


Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
MedLine Citation:
PMID:  11527128     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Combined treatment of beta-adrenoceptor-blocking agents and class I antiarrhythmic drugs can potentially have profound and deleterious effects on cardiac impulse formation and conduction. We studied the effect of 5 mg of oral bisoprolol daily and 10 mg/kg of procainamide intravenously with programmed electrical stimulation of the heart in 10 patients with postinfarction ventricular tachyarrhythmias. Oral bisoprolol slowed sinus rhythm and atrioventricular nodal conduction; ventricular effective refractory periods were increased significantly after several days of oral bisoprolol treatment. Combined treatment of oral bisoprolol and intravenous procainamide did not produce clinically relevant changes in parameters of cardiac impulse formation and conduction. This study shows that combined use of bisoprolol and a class I antiarrhythmic drug appears to be safe in patients with ventricular tachyarrhythrhythmias late after myocardial infarction.
Authors:
J M Verrostte; N M van Hemel; J H Kingma
Related Documents :
2766508 - Diagnostic value of qrst isointegral maps in detecting myocardial infarction complicate...
7463728 - Lipoma of the heart in a child. clinical, echocardiographic, angiographic, and patholog...
3761528 - Histological findings of the right and left ventricular myocardium and clinical follow ...
1960328 - Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular t...
3827408 - Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with li...
11096678 - Restenosis: relationship with thrombosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  16 Suppl 5     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1990  
Date Detail:
Created Date:  2001-08-30     Completed Date:  2001-09-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S193-5     Citation Subset:  IM    
Affiliation:
Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adrenergic beta-Antagonists / administration & dosage*
Adult
Aged
Anti-Arrhythmia Agents / administration & dosage*
Atrioventricular Node / drug effects,  physiology
Bisoprolol / administration & dosage*
Drug Interactions
Drug Therapy, Combination
Electrocardiography / drug effects*
Electrophysiologic Techniques, Cardiac / methods
Heart Conduction System / drug effects*
Humans
Infusions, Intravenous
Middle Aged
Myocardial Infarction / drug therapy
Procainamide / administration & dosage*
Tachycardia, Ventricular / drug therapy
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 51-06-9/Procainamide; 66722-44-9/Bisoprolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular reactivity to and renal impact of stress and exercise: effects of bisoprolol.
Next Document:  Bisoprolol pilot studies in myocardial infarction.